טוען...
New agents for the treatment of drug-resistant Mycobacterium tuberculosis
Inadequate dosing and incomplete treatment regimens, coupled with the ability of the tuberculosis bacilli to cause latent infections that are tolerant of currently used drugs, have fueled the rise of multidrug-resistant tuberculosis (MDR-TB). Treatment of MDR-TB infections is a major clinical challe...
שמור ב:
| הוצא לאור ב: | Adv Drug Deliv Rev |
|---|---|
| Main Authors: | , , , |
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
2016
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4903924/ https://ncbi.nlm.nih.gov/pubmed/27151308 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2016.04.026 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|